GLUCOREGULATORY PEPTIDE HORMONES
GLUCOREGULATORY PEPTIDE HORMONES
批准号:
2608343
负责人:
Roger Harold Unger
金额:
$11.64万
依托单位国家:
美国
项目类别:
财政年份:
1977
资助国家:
美国
项目状态:
已结题
起止时间:
1977-12-01 至 1998-11-30
关键词:
diabetes mellitus diabetes mellitus therapy dogs gastrointestinal hormones glucagon glucose metabolism histochemistry /cytochemistry hormone inhibitor hormone receptor hormone regulation /control mechanism hormone therapy human tissue hyperglycemia hypoglycemic agents immunochemistry insulin laboratory rat metabolism disorder chemotherapy pancreatic islet function secretion somatostatin tissue /cell culture
中文摘要
当胰岛β细胞丢失时,胰岛素抵抗患者就会患上糖尿病。
正常的对葡萄糖的反应能力和对前
存在胰岛素抵抗。找出贝塔细胞缺陷
结果在NIDDM中,我们计划在大鼠身上表征分子,
正常β细胞代偿的代谢和生理成分
1)高血糖钳夹反应,2)地塞米松反应
治疗,以及3)肥胖,并将这些与不同类型的β细胞进行比较
不能补偿这些相同因素的大鼠模型(如ZDF-DRT大鼠,
GK大鼠、Zucker FA/FA大鼠和亚糖尿病链脲佐菌素大鼠
治疗)。功能测量包括1)胰岛素对5的反应,
10、20 mM葡萄糖、甘油醛和琥珀酸单甲酯定位
一块,2)葡萄糖运输代谢、利用、
氧化和葡糖激活酶活性进一步定位这种封闭,3)
胰岛β细胞原、GLUT-2、葡萄糖激酶和G蛋白的定量测定
确定关键蛋白表达是否受损的Alpha mRNA,4)
百分GLUT-2和含β-葡萄糖激活剂的形态计量学分析
细胞质量通过免疫细胞化学,5)β细胞体积,以确定
受损的β细胞团的扩张和形态计量学评估
通过电子显微镜观察线粒体的完整性。纵向
测量将从前六周开始每周进行一次,
直到糖尿病发作后六周。希望能找到一种
不同糖尿病大鼠模型的一致性差异
正常的代偿反应的重要组成部分,可能指向
致病基因。
英文摘要
Insulin resistant individuals become diabetic when beta-cells lose their
normal ability to respond to glucose and to compensate for the pre-
existing insulin resistance. To identify the beta-cell defect that
results in NIDDM, we plan to characterize in rats the molecular,
metabolic and physiologic components of the normal beta-cell compensatory
response induced 1) by hyperglycemic clamping, 2) by dexamethasone
treatment, and 3) by obesity and compare these with beta-cells of various
rat models that cannot compensate these same factors (eg ZDF-drt rats,
GK rats, Zucker fa/fa rats and rats after subdiabetic streptozotocin
treatment). Functional measurement include 1) insulin responses to 5,
10, 20 mM glucose, glyceraldehyde and monomethyl succinate to localize
a block, 2) measurements of glucose transport metabolism, utilization,
oxidation and glucokinase activity further to localize such a block, 3)
quantitation of beta-cell proinsulin, GLUT-2, glucokinase and G protein
alpha mRNA to determine if expression of key proteins is impaired, 4)
morphometric analysis of percent GLUT-2 and glucokinase containing beta-
cell mass by immunocytochemistry, 5) beta-cell volume to determine if
expansion of the beta-cell mass impaired and 6) morphometric assessment
of mitochondrial integrity by electronmicroscopy. Longitudinal
measurements will be made a weekly intervals from six weeks before and
until six weeks after the onset of diabetes. The hope is to find a
consistent difference in various diabetic rat models of seemingly
crucial component of the normal compensatory response that might point
to the pathogenic locus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ectopic Lipids in the Pancreatic Alpha Cell Link Insulin Resistance to Hyperglycemia
-
批准号:9241626
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Roger Harold Unger
-
依托单位:
Ectopic Lipids in the Pancreatic Alpha Cell Link Insulin Resistance to Hyperglycemia
-
批准号:9412379
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Roger Harold Unger
-
依托单位:
Trihormonal Regulation of Metabolic Homeostasis: Redesigning Therapy of Diabetes
-
批准号:8250818
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Roger Harold Unger
-
依托单位:
Trihormonal Regulation of Metabolic Homeostasis: Redesigning Therapy of Diabetes
-
批准号:8044623
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Roger Harold Unger
-
依托单位:
Trihormonal Regulation of Metabolic Homeostasis: Redesigning Therapy of Diabetes
-
批准号:8392966
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Roger Harold Unger
-
依托单位:
GLUCOREGULATORY PEPTIDE HORMONES
-
批准号:7357892
-
项目类别:
-
资助金额:$1.17万
-
财政年份:2006
-
负责人:Roger Harold Unger
-
依托单位:
GLUCOREGULATORY PEPTIDE HORMONES
-
批准号:7180731
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2005
-
负责人:Roger Harold Unger
-
依托单位:
GLUCOREGULATORY PEPTIDE HORMONES
-
批准号:6977501
-
项目类别:
-
资助金额:$0.96万
-
财政年份:2004
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B CELL IMPAIRMENT/DESTRUCTION
-
批准号:2142397
-
项目类别:
-
资助金额:$99.62万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B-CELL IMPAIRMENT-DESTRUCTION
-
批准号:3095612
-
项目类别:
-
资助金额:$93.39万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B CELL IMPAIRMENT/DESTRUCTION
-
批准号:2142398
-
项目类别:
-
资助金额:$7.28万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B-CELL IMPAIRMENT-DESTRUCTION
-
批准号:3095608
-
项目类别:
-
资助金额:$97.33万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B-CELL IMPAIRMENT-DESTRUCTION
-
批准号:3095610
-
项目类别:
-
资助金额:$6.82万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B-CELL IMPAIRMENT-DESTRUCTION
-
批准号:3095613
-
项目类别:
-
资助金额:$94.25万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B-CELL IMPAIRMENT-DESTRUCTION
-
批准号:3095611
-
项目类别:
-
资助金额:$88.21万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B CELL IMPAIRMENT/DESTRUCTION
-
批准号:2142399
-
项目类别:
-
资助金额:$15.62万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B-CELL IMPAIRMENT-DESTRUCTION
-
批准号:3095609
-
项目类别:
-
资助金额:$4.41万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
GLUCOREGULATORY PEPTIDE HORMONES
-
批准号:2134413
-
项目类别:
-
资助金额:$11.57万
-
财政年份:1977
-
负责人:Roger Harold Unger
-
依托单位:
THE GLUCOREGULATORY PEPTIDE HORMONES
-
批准号:3150694
-
项目类别:
-
资助金额:$10.42万
-
财政年份:1977
-
负责人:Roger Harold Unger
-
依托单位:
GLUCOREGULATORY PEPTIDE HORMONES
-
批准号:2758327
-
项目类别:
-
资助金额:$16.67万
-
财政年份:1977
-
负责人:Roger Harold Unger
-
依托单位: